Abstract
Introduction: In patients undergoing neo-adjuvant chemotherapy, staging of the axilla prior to treatment may spare them an unnecessary axillary clearance post treatment. In February 2011 our centre introduced ultrasound (+/- FNA) and, if negative, sentinel lymph node biopsy (SLNB) for all neo-adjuvant patients prior to commencing treatment. This study aimed to assess the impact of this change in practice on this cohort of patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
